Letter by Lavine Regarding Article, “Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.